New model forecasts cancer recurrence risk in rectal patients
NCT ID NCT07351708
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to create a model that predicts whether rectal cancer will come back after treatment. Researchers looked at medical records and inflammation markers from over 2,300 patients with advanced rectal cancer who had chemotherapy or radiation before surgery. The goal was to help doctors identify patients at higher risk of local recurrence, so they can plan better follow-up care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED RECTAL CANCER (LARC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a gut bacteria transplant help immunotherapy wipe out rectal cancer before surgery?
- New combo therapy aims to shrink rectal tumors before Surgery—Could spare some patients the knife
- New combo therapy aims to spare organs in High-Risk rectal cancer
- New drug duo takes on tough rectal cancer
- Blood test may predict rectal cancer treatment success
- New drug combo may help avoid surgery in rectal cancer patients